tiprankstipranks
Trending News
More News >
Coty (COTY)
NYSE:COTY

Coty (COTY) AI Stock Analysis

Compare
1,787 Followers

Top Page

COTY

Coty

(NYSE:COTY)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$2.50
▼(-4.21% Downside)
The score is held back primarily by the recent swing to net losses and weak technical trend signals (price below key moving averages with negative MACD). Solid cash flow generation and the Wella divestiture/deleveraging plan provide support, but management’s guidance points to continued near-term pressure with a longer-dated profit recovery.
Positive Factors
Brand Portfolio Diversification
Coty’s multi‑segment brand portfolio (Luxury, Consumer, Professional) and licensing model spreads revenue across channels and price points. This diversification reduces dependency on any single franchise or geography, supporting resilient cash flow and allowing reallocation of resources to higher‑growth brands over time.
Strong Cash Generation
Consistent positive operating and free cash flow provides durable capacity to service debt, fund innovation and support restructuring without relying solely on earnings. Strong cash conversion cushions near‑term profit volatility and gives management flexibility to invest in e‑commerce and productivity initiatives over the medium term.
Wella Divestiture & Deleveraging
Monetizing the Wella stake converts a non‑core, illiquid holding into substantial cash for debt reduction and strategic focus. Reducing leverage improves financial flexibility and lowers interest burdens, allowing management to concentrate capital on core beauty segments and brand innovation with a clearer capital allocation lens.
Negative Factors
Elevated Leverage & Constrained Balance Sheet
Meaningful leverage limits flexibility if profitability remains pressured and raises refinancing risk in adverse markets. Even with sizable equity, negative returns on equity and elevated net leverage reduce the company’s ability to pursue opportunistic M&A or accelerate reinvestment without first restoring sustained profit recovery.
Profitability Deterioration
A sharp swing to net losses and negative margins undermines durable earnings power and delays internal reinvestment. Accounting losses, even with positive cash flow, erode retained capital and heighten execution risk; management projects a clearer profit recovery only by fiscal 2027, prolonging performance uncertainty.
Consumer Beauty Underperformance & SKU Issues
Chronic underperformance in Consumer Beauty, combined with prior over‑innovation and SKU proliferation, produces trade returns, promotional pressure and inventory actions that depress sell‑in and margins. Remediation (SKU pruning, portfolio rationalization) improves long‑term efficiency but creates near‑term revenue and execution drag.

Coty (COTY) vs. SPDR S&P 500 ETF (SPY)

Coty Business Overview & Revenue Model

Company DescriptionCoty Inc., together with its subsidiaries, engages in the manufacture, marketing, distribution, and sale of beauty products worldwide. The company provides prestige fragrances, skin care, and color cosmetics products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Alexander McQueen, Burberry, Bottega Veneta, Calvin Klein, Cavalli, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lacoste, Lancaster, Marc Jacobs, Miu Miu, Nikos, philosophy, Kim Kardashian West, and Tiffany & Co. brands. It also offers mass color cosmetics, fragrance, skin care, and body care products primarily through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, Stetson, and 007 James Bond brands. Coty Inc. also sells its products through third-party distributors to approximately 150 countries and territories. The company was founded in 1904 and is based in New York, New York. Coty Inc. is a subsidiary of Cottage Holdco B.V.
How the Company Makes MoneyCoty generates revenue primarily through the sale of beauty products across its different segments. The Luxury segment focuses on high-end fragrances and cosmetics, contributing significantly to overall sales, particularly through partnerships with prestigious fashion houses. The Consumer Beauty segment includes mass-market cosmetics and skincare products, which are widely distributed through retail channels such as drugstores and supermarkets. The Professional Beauty segment, which includes salon products, leverages partnerships with hair salons and stylists to drive sales. Additionally, Coty benefits from licensing agreements that allow it to produce and sell products under various brand names. The company's strategic collaborations, such as those with e-commerce platforms and beauty influencers, also play a crucial role in enhancing its market reach and driving revenue growth.

Coty Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where Coty is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsCoty's revenue in the Americas and EMEA regions shows volatility, with recent declines in 2025. Despite this, the EMEA region remains a strong performer, likely buoyed by Coty's leadership in the prestige fragrance market. The APAC region, while smaller, has shown resilience with steady performance. The earnings call highlights challenges in the U.S. market and a 9% Q4 revenue decline, but management is optimistic about a turnaround in the latter half of fiscal 2026, driven by strategic investments and new fragrance launches.
Data provided by:The Fly

Coty Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 11, 2026
Earnings Call Sentiment Neutral
The call presented a mix of tangible near‑term challenges and concrete remediation plans. Near‑term results are pressured—mid‑single‑digit Q3 revenue decline, Q2 gross margin weakness driven by promotions, FX and tariffs, and Consumer Beauty underperformance with recovery targeted for fiscal 2027. Offsetting strengths include strong e‑commerce momentum (Amazon +30% in 6 months), successful innovations (e.g., Boss Bottled Beyond), productivity opportunities from AI (70%–80% asset cost reduction potential), and a clear pipeline of new licensed product initiatives. Management emphasized discipline, SKU rationalization, data/AI investments and channel focus to drive sell‑out and margin recovery over time.
Q2-2026 Updates
Positive Updates
E‑commerce and New Channel Momentum
Prestige sales on Amazon have grown ~30% over the last 6 months; a July Marc Jacobs launch on Amazon is driving double‑digit growth. Activity in TikTok Shop (e.g., Rimmel in the U.K.) is generating marketing halo effects that boost brick‑and‑mortar performance.
Successful New Product Performance
Boss Bottled Beyond launched in summer and is the #2 male initiative of the year, delivering ~90 basis points share in the U.S. for Hugo Boss innovation.
AI and Marketing Productivity Gains
Experiments in AI for color cosmetics asset creation indicate potential cost reductions of 70%–80% versus current processes, enabling reallocation of funds into working media and consumer‑facing activities.
Pipeline of New Brand and License Opportunities
Management highlighted new/renewed licenses (Swarovski, Armani, Etro) and is planning a potential blockbuster for Swarovski in 2027; Calvin Klein and Marc Jacobs innovations are slated as near‑term growth drivers.
Fragrance Category Demand and Volume Trends
Company expects the fragrance category to continue growing mid‑single digits; management reported continued household penetration and new consumer inflows (Gen Z) into the category.
Operational and Data Investments
Leadership is investing in a single source‑of‑truth data lake, AI and analytics to improve sell‑out focus, joint business planning with retailers, SKU rationalization and SG&A/platform optimization — intended to drive recoveries starting fiscal 2027.
Negative Updates
Consumer Beauty Underperformance and Sell‑out Weakness
Consumer Beauty has materially underperformed corporate averages; several core color cosmetics franchises were declining in the high single digits and have only moved to low‑ to mid‑single‑digit declines after early initiatives. Management expects Consumer Beauty improvements primarily in fiscal 2027.
Near‑term Revenue Pressure: Q3 Guidance
Company expects a mid‑single‑digit sales decline in Q3, with Consumer Beauty the main drag. Management warned of sequential deterioration in Q3 before planned recovery later in the year and into FY27.
Gross Margin Pressure and Promotional Environment
Q2 gross margin came in below initial expectations, with management and analysts referencing a 200–300 bps margin contraction dynamic. Key drivers cited: elevated promotional activity and markdowns (notably in Prestige), trade term pressure and competitive promotional aggression persisting into Q3.
Volume‑Related Fixed Cost Under‑absorption and Mix Headwinds
Lower volumes in color cosmetics are creating fixed cost under‑absorption that is hurting gross margins; geographic mix pressure (strong growth in lower‑margin markets like Brazil vs. softness in higher‑margin U.S. brands) also weighed on margins.
Tariffs, FX and One‑time Headwinds
Tariffs were approximately $8 million in Q2 and are expected to be below $40 million for the full year; FX (euro‑dollar) and shifting production footprint are also cited as headwinds to gross margin in the near term.
SKU Proliferation, Over‑innovation and Inventory Actions
Management acknowledged excess SKU proliferation and 'gigantic' innovation bundles in prior periods that crowded productive SKUs, led to trade returns and required portfolio pruning and returns/stock adjustments—actions that depress near‑term sell‑in and revenue while intended to improve long‑term sell‑out.
Company Guidance
Coty guided to a mid-single-digit sales decline in Q3 driven mainly by Consumer Beauty, warned of continued gross‑margin pressure into Q3 with a sequential recovery expected in Q4 and a clearer profit recovery by fiscal 2027, and cited specific metrics and headwinds including $8M of tariffs in Q2 (expected to be below $40M for the full year), promotional/markdown pressure that weighed on Q2 gross margins, stronger Amazon performance (Prestige sales up ~30% over the last six months; a Marc Jacobs Amazon launch delivering double‑digit growth), innovation wins like Boss Bottled Beyond (already ~90 basis points U.S. share), SKU declines on key franchises moving from high single‑digit drops to low‑/mid‑single digits, experiments cutting asset‑creation costs by ~70–80%, many brands with >$0.5B potential, and the Gucci license exit in June 2028 — all framed by an objective to prioritize sell‑out, streamline SKUs and reinvest savings to drive market‑share and margin improvement.

Coty Financial Statement Overview

Summary
Mixed fundamentals: revenue growth and consistently strong gross margins are offset by a sharp swing to significant net losses and negative returns on equity. Free cash flow and operating cash flow remain solid and supportive, but elevated leverage reduces flexibility if profitability stays pressured.
Income Statement
46
Neutral
Revenue has grown in the most recent TTM (Trailing-Twelve-Months) period (+15%), but profitability has weakened sharply: net income is deeply negative (about -$534M) and margins turned negative, versus solid profitability in FY2022–FY2024 (including positive net income in FY2022–FY2024 and notably strong FY2023). Gross margin remains high and stable (~64–65%), but the drop from positive operating profit in FY2023–FY2024 to weak/negative profitability in TTM raises concern about sustainability and earnings quality near-term.
Balance Sheet
50
Neutral
Leverage is elevated with debt running around ~1.0–1.5x equity across the period, which limits flexibility if profits stay pressured. Equity is sizable (~$3.5B in TTM), but returns on equity are negative in TTM and FY2025, following stronger positive returns in FY2022–FY2024. Overall, the balance sheet is serviceable but constrained by meaningful leverage and a recent deterioration in shareholder returns.
Cash Flow
68
Positive
Cash generation is a bright spot: TTM operating cash flow is strong (~$586M) and free cash flow is solid (~$394M), with very strong TTM free cash flow growth. Free cash flow has remained positive across all years shown, supporting debt service and reinvestment capacity. The key weakness is that cash flow strength is occurring alongside reported net losses in TTM and FY2025, indicating a gap between accounting earnings and cash results that bears monitoring.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue5.81B5.89B6.12B5.55B5.30B4.63B
Gross Profit3.63B3.82B3.94B3.55B3.38B2.78B
EBITDA70.80M949.90M1.00B964.90M856.30M744.50M
Net Income-530.20M-367.90M89.40M508.20M259.50M-201.30M
Balance Sheet
Total Assets11.08B11.91B12.08B12.66B12.12B13.69B
Cash, Cash Equivalents and Short-Term Investments448.00M257.10M300.80M246.90M233.30M253.50M
Total Debt3.62B4.25B4.12B4.55B4.78B5.80B
Total Liabilities7.27B7.95B7.83B8.43B8.56B9.51B
Stockholders Equity3.53B3.69B3.97B3.95B3.30B3.90B
Cash Flow
Free Cash Flow393.80M277.60M369.40M402.90M552.50M144.80M
Operating Cash Flow585.60M492.60M614.60M625.70M726.60M318.70M
Investing Cash Flow638.50M-128.40M-226.20M-118.20M269.70M2.44B
Financing Cash Flow-1.07B-426.80M-336.70M-469.30M-1.03B-2.80B

Coty Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.61
Price Trends
50DMA
3.10
Negative
100DMA
3.46
Negative
200DMA
4.10
Negative
Market Momentum
MACD
-0.18
Positive
RSI
36.20
Neutral
STOCH
11.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For COTY, the sentiment is Negative. The current price of 2.61 is below the 20-day moving average (MA) of 2.96, below the 50-day MA of 3.10, and below the 200-day MA of 4.10, indicating a bearish trend. The MACD of -0.18 indicates Positive momentum. The RSI at 36.20 is Neutral, neither overbought nor oversold. The STOCH value of 11.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for COTY.

Coty Risk Analysis

Coty disclosed 44 risk factors in its most recent earnings report. Coty reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Coty Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$3.23B19.6919.95%3.80%3.12%9.01%
68
Neutral
$1.79B18.114.92%3.15%-5.21%1.96%
64
Neutral
$5.15B49.7610.77%13.80%-25.02%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
55
Neutral
$40.56B-223.07-4.34%1.30%-6.36%-554.84%
52
Neutral
$1.03B-26.091.62%3.51%-1.34%-73.59%
51
Neutral
$2.25B-4.19-14.50%-5.68%-358.36%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
COTY
Coty
2.61
-2.92
-52.80%
EL
The Estée Lauder Companies
111.60
41.44
59.06%
IPAR
Inter Parfums
101.13
-29.12
-22.36%
SPB
Spectrum Brands Holdings
78.32
1.12
1.45%
EPC
Edgewell Personal Care
22.10
-7.15
-24.43%
ELF
e.l.f. Beauty
88.04
14.93
20.42%

Coty Corporate Events

Business Operations and StrategyExecutive/Board Changes
Coty Overhauls Leadership With New Executive Chairman CEO
Neutral
Dec 22, 2025

On December 20, 2025, Coty’s board appointed former Procter & Gamble executive Markus Strobel as Executive Chairman and Interim CEO, effective January 1, 2026, with a significant compensation package of salary, bonus eligibility and long-term equity incentives tied to service and performance through 2028. Strobel, known for leading P&G’s Global Skin & Personal Care business and revitalizing prestige brands in Asia and other key regions, will guide Coty at what the company calls a pivotal moment, as it conducts a strategic review of its Consumer Beauty division and seeks to consolidate its leadership and profitable growth prospects in both prestige and mass beauty. The leadership changes also include the planned separation of CEO Sue Y. Nabi, who will step down and leave the board on December 31, 2025 under a separation agreement that provides cash in lieu of notice and partial vesting of restricted stock units, while other unvested equity is forfeited. In parallel, long-standing Chairman Peter Harf will resign from the board on December 31, 2025 after more than three decades of involvement, to be succeeded in board leadership by Strobel and joined by new director Patricia Capel, who will take a board seat and join the Remuneration and Nomination Committee on January 1, 2026, reflecting a broad reshaping of Coty’s top governance structure.

The most recent analyst rating on (COTY) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Coty stock, see the COTY Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Coty Completes Wella Divestiture to Sharpen Core Focus
Positive
Dec 19, 2025

On December 18, 2025, Coty JV Holding S.à r.l., an indirect subsidiary of Coty Inc., agreed to sell its remaining shareholdings in Rainbow JVCo, which represents Coty’s residual 25.8% stake in professional haircare group Wella, to KKR-managed entities for $750 million in cash plus a non-cash consideration that will give Coty JV a 45% equity interest in the buyer vehicle and rights to a significant share of future Wella exit proceeds. As part of the transaction, Coty JV entered into a new shareholders’ agreement that grants it consent rights on certain corporate actions at the buyer level, board observer rights, and tag-along and drag-along protections, while terminating a prior shareholders’ agreement related to Rainbow JVCo, and Coty expects to record an estimated non-cash impairment charge of approximately $200 million in the quarter ended December 31, 2025. The deal, announced on December 19, 2025, completes Coty’s multi-year program begun in 2020 to monetize and fully divest its Wella stake by the end of calendar 2025, simplifies Coty’s portfolio, and is intended to substantially reduce its financial net leverage through debt repayment using most of the $750 million upfront proceeds, reinforcing its deleveraging strategy and sharpening its strategic focus on core beauty operations.

The most recent analyst rating on (COTY) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Coty stock, see the COTY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026